Exenatide (Ex), a 39-amino-acid GLP-1 analogue peptide, is a potent agonist with high affinity for GLP-1Rs and has a significantly longer biological half-life than the exogenously administered GLP-1, which makes it an efficient treatment option in noninsulin-dependent diabetes mellitus [14,15,16,17]
For the use of the product during pregnancy and breastfeeding it is advisable to consult your doctor
A good rule of thumb is to take it first thing in the morning or at least 30 to 60 minutes before you eat anything
Cagrilintide may have a lower incidence of vomiting than GLP-1 receptor agonists, but it still has the potential to over-suppress your appetite
Grants were paid to the institution, Hvidovre Hospital, University of Copenhagen, with no personal fee
Side effects like migraines, mood swings, weight gain, and vaginal bleeding may occur